Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SCHG✓SelectedUSD · SCHGGSK vs SCHG performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs SCHG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
SCHG return
+57.2%
Excess return
-4.4%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioSCHGExcessAlpha
1D-0.1%-5.2%+5.1%+0.3%
7D-5.3%-10.3%+5.0%-4.5%
30D-3.7%-14.9%+11.2%-2.5%
3M-7.3%-12.9%+5.7%-6.3%
6M-4.2%-10.8%+6.6%-3.5%
YTD+0.9%-6.1%+7.0%+0.9%
1Y+7.3%-1.6%+8.9%+6.9%
3Y+52.7%+55.3%-2.6%+43.5%
All+52.7%+57.2%-4.4%+43.5%

Cumulative growth

Daily Returns

Daily percentage return beside SCHG.

Daily Out/Under-Performance

Portfolio return minus SCHG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SCHG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded SCHG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling